Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL-lpr mice

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3805-3811

  Fukuyama, Hidehiro ^a,b   Adachi, Masashi ^a   Suematsu, Sachiko ^c,d   Miwa, Keiko ^a   Suda, Takashi ^a   Yoshida, Nobuaki ^c   Nagata, Shigekazu ^a,b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

^c RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^d BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD45 ANTIGEN; FAS ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; GLOMERULONEPHRITIS; LIGAND BINDING; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; SPLENOMEGALY; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGENS, CD95; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; GENE EXPRESSION; IMMUNOGLOBULIN G; LYMPHATIC DISEASES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 0032522665     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75:1169.
2. Nagata, S. 1997. Apoptosis by death factor. Cell 88:365.
3. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in T-cell-lineage. J. Immunol. 154:3806.
4. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235.
5. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
6. Itoh, N., S. Yonehara. A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
7. Schattner, E. J., K. B. Elkon, D.-H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
8. Wang, J., I. Taniuchi, Y. Maekawa, M. Howard, M. D. Cooper, and T. Watanabe. 1996. Expression and function of Fas antigen on activated murine B cells. Eur. J. Immunol. 26:92.
9. Watanabe, D., T. Suda, and S. Nagata. 1995. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int. Immunol. 7:1949.
10. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathway as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
11. Cohen, P. L., and R. A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
12. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16:39.
13. Adachi, M., S. Suematsu, T. Suda, D. Watanabe, H. Fukuyama, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1996. Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93:2137.
14. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. G. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villarty. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
15. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
16. Bettinardi, A., D. Brugnoni, E. Quiròs-Roldan, A. Malagoli, S. La Grutta, A. Correra, and L. D. Notarangelo. 1997. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 89:902.
17. Wu, J., J. Wilson, J. He, L. Xiang, P. H. Schur, and J. D. Mountz. 1996. Fas ligand mutation in a patient with the systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98:1107.
18. Drappa, J., A. K. Vaishnaw, K. E. Sullivan, J. L. Chu, and K. B. Elkon. 1996. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335:1643.
19. Sneller, M. C., J. Wang, J. K. Dale, W. Strober, L. A. Middelton, Y. Choi, T. A. Fleisher, M. S. Lim, E. S. Jaffe, J. M. Puck, M. J. Lenardo, and S. E. Straus. 1997. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 89:1341.
20. Watanabe, D., T. Suda, H. Hashimoto, and S. Nagata. 1995. Constitutive activation of the fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
21. Giese, T., and W. F. Davidson. 1992. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr. J. Immunol. 149:3097.
22. Dhein, J., H. Walczak, C. Bäumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
23. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
24. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rotnstein. 1995. Fas (CD95)/FasL interaction required for programmed cell death after T-cell activation. Nature 373:444.
25. Russell, J. H., B. Rush, C. Weaver, and R. Wang. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. USA 90:4409.
26. Giese, T., and W. F. Davidson. 1994. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production. J. Immunol. 152:2000.
27. Jacobsen, B. A., D. J. Panka, K.-A. Nguyen, J. Erikson, A. K. Abbas, and A. Marshak-Rothstein. 1995. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3:509.
28. + T cells. Nature 376:181.
29. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319.
30. Chaffin, K. E., C. R. Beals, T. M. Wilkie, K. A. Forbush, M. I. Simon, and R. M. Perlmutter. 1990. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9:3821.
31. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148:1274.
32. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
33. Adachi, M., S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in the peripheral lymphoid organs and liver. Nat. Genet. 11:294.
34. Suda, T., M. Tanaka, K. Miwa, and S. Nagata. 1996. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J. Immunol. 157:3918.
35. Sedivy, J. M. 1993. New genetic methods for mammalian cells. Biol. Technol. 6:1192.
36. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179:873.
37. Rasmussen, S. R., M. R. Larsen, and S. E. Rasmussen. 1991. Covalent immobilization of DNA onto polystyrene microwells: the molecules are only bound at the 5′ end. Anal. Biochem. 198:138.
38. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by detects in Fas antigen that mediates apoptosis. Nature 356:314.
39. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90:1756.
40. Klinman, D. M. 1990. IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-γ. J. Immunol. 144:2529.
41. Wu, J., T. Zhou, J. Zhang, J. He, W. C. Gause, and J. D. Mountz. 1994. Correction of accelerated autoimmune disease by early replacement of the mutated lpr gene with the normal fas apoptosis gene in the T cells of transgenic MRL-lpr/lpr mice. Proc. Natl. Acad. Sci. USA 91:2344.
42. Yagita, H., T. Nakamura, H. Karasuyama, and K. Okumura. 1989. Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells. Proc. Natl. Acad. Sci. USA 86:645.
43. Sen, J., N. Rosenberg, and S. Burakoff. 1990. Expression and ontogeny of CD2 on murine B cells. J. Immunol. 144:2925.
44. Sobel, E. S., P. L. Cohen, and R. A. Eisenberg. 1993. lpr T cells are necessary for autoantibody production in lpr mice. J. Immunol. 150:4160.
45. Goodnow, C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93:2246.
46. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M. K. Kennedy, and D. H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545.
47. Korthäuer, U., D. Graf, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, and R. A. Kroczek. 1993. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper IgM. Nature 361:539.
48. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of lyn-deficient mice, culminating in autoimmune disease. Cell 83:301.
49. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549.
50. Wang, J., T. Koizumi, and T. Watanabe. 1996. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. J. Exp. Med. 184:831.
51. Peng, S. L., J. M. McNiff, M. P. Madaio, J. Ma, M. J. Owen, R. A. Flavell, A. C. Hayday, and J. Craft. 1997. αβ T cell regulation and CD40 ligand dependence in murine systemic autoimmunity. J. Immunol. 158:2464.
52. MacLennan, I. C. M. 1994. Germinal centers. Annu. Rev. Immunol. 12:117.